SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-24-014080
Filing Date
2024-02-14
Accepted
2024-02-14 16:30:28
Documents
2
Group Members
VIVO OPPORTUNITY, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea193791-13gvivo_adverum.htm SC 13G 68339
2 JOINT FILING AGREEMENT ea193791ex99-1_adverum.htm EX-99.1 4612
  Complete submission text file 0001213900-24-014080.txt   74637
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88266 | Film No.: 24639068
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Opportunity Fund Holdings, L.P. (Filed by) CIK: 0001930214 (see all company filings)

IRS No.: 873802421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G